NEO-ZOTAC: Toxicity data of a phase Ill randomized trial with NEOadjuvant chemotherapy (TAC) with or without ZOledronic acid (ZA) for patients with HER2-negative large resectable or locally advanced breast cancer (BC)

Author(s):: Yen, S.V. de; Liefers, G.J.; Putter, H.; Warmerdam, L.J. van; Kessels, L.W.; Dercksen, W.; Pepels, M.J.; Maartense, E.; Laarhoven, H.W.M. van; Vriens, B.; Smit, V.T.H.B.M.; Wasser, M.N.J.M.; Meershoek-Klein, K.E.M.; Leeuwen-Stok, E. van; Velde, C.J.H. van de; Nortier, J.W.R.; Kroep, J.R.